Atara Biotherapeutics (AT20.F) Q1 2025 Earnings

7MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-5.95
-4.33
-2.72
-1.1

Details

Expected EPS
-2.6395456835999997
Actual EPS
-1.097894
Surprise EPS
1.54
Surprise Percent
+58.41%

Description

Atara Biotherapeutics (AT20.F) has reported earnings of -1.097894 per share for Q1 2025.

0 Comments

Share your thoughts